Reuters: Health News
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.
U.S. jury fails to reach verdict in latest J&J talc trial
25 May 2018 at 4:22pm
NEW YORK (Reuters) - A South Carolina jury on Friday could not agree on a verdict in a case of a woman whose family said her long-term use of Johnson & Johnson's Baby Powder led to her death from asbestos-related cancer, resulting in a mistrial.
Fear and suspicion hinder Congo medics in Ebola battle
25 May 2018 at 9:07am
DAKAR (Reuters) - With more than twice as many Ebola outbreaks as any other country since the virus was discovered in 1976, Congolese are familiar with its destructive power, yet fear and suspicion of medical authorities are still hindering efforts at containment.
AstraZeneca cancer drug hits second goal by extending survival
25 May 2018 at 12:31am
LONDON (Reuters) - AstraZeneca's immunotherapy drug Imfinzi has hit a second important goal by improving overall survival in lung cancer patients, boosting prospects for a medicine that has already got off to a promising commercial launch.
Third Indian state checks suspect cases in outbreak of rare brain-damaging virus
25 May 2018 at 1:55am
MUMBAI (Reuters) - Officials in a third Indian state were checking on Friday if two people had been infected with the brain-damaging Nipah virus that has killed 12 in southern Kerala, although the government described the outbreak as minor.
Women who freeze eggs to delay childbirth often feel regret
25 May 2018 at 10:58am
(Reuters Health) - For the past four years, since Facebook and Apple began paying for employees to freeze their eggs to delay childbirth, healthy women are increasingly trying to slow their biological clocks by banking their oocytes, or eggs.
Food insecurity linked to type 2 diabetes risk
25 May 2018 at 9:52am
(Reuters Health) - Canadians who cannot afford to eat regularly or to eat a healthy diet have more than double the average risk of developing type 2 diabetes, a study suggests.
VA health systems vary widely in heart disease death rates
25 May 2018 at 11:03am
(Reuters Health) - Heart disease death rates vary substantially at Veterans Affairs hospitals nationwide, and a new study suggests that this holds true not just for hospitalized patients but also for outpatients.
J&J must pay $4 million in punitive damages in latest asbestos cancer trial
24 May 2018 at 12:22pm
(Reuters) - A California jury on Thursday ordered Johnson & Johnson to pay $4 million in punitive damages to a woman who said she developed cancer after being exposed to asbestos in the company's baby powder, pushing the total damages award in the case to $25.7 million.
FDA approves BioMarin rare metabolic disorder drug, shares rise
24 May 2018 at 7:42pm
(Reuters) - U.S. regulators on Thursday approved BioMarin Pharmaceutical Inc's Palynziq for adults with phenylketonuria, a rare metabolic disorder, sending shares of the biotechnology company up 3 percent after hours.
Pressured by industry, U.S. EPA slows formaldehyde study release: documents
24 May 2018 at 5:12pm
WASHINGTON (Reuters) - The U.S. Environmental Protection Agency, under pressure from the chemical industry, has delayed release of a study detailing cancer risks from formaldehyde, according to internal communications seen by Reuters, potentially keeping important health information from the public.